Skip to content

H.R. 124 · 118th Congress (2023–2025)

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Show official title

To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 124’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Al Green (D-TX-9)
Cosponsors
3 cosponsors

0 original · 3 later

  1. Rep. Don Bacon (R-NE-2)· Later · Feb 23, 2024
  2. Del. Eleanor Holmes Norton (D-DC)· Later · Feb 23, 2024
  3. Rep. Bennie G. Thompson (D-MS-2)· Later · Feb 23, 2024
Policy area
Health
Subjects
  • Cancer
  • Digestive and metabolic diseases
  • Health promotion and preventive care
  • Medicaid

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Jan 9, 2023 – Jan 20, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 9, 2023
  2. HouseHealthReferred Jan 20, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

    Display title, Short title · Introduced in House

  2. To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.

    Official title · Introduced in House